BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18500266)

  • 1. Expression of c-kit in fibroepithelial lesions of the breast is a mast cell phenomenon.
    Djordjevic B; Hanna WM
    Mod Pathol; 2008 Oct; 21(10):1238-45. PubMed ID: 18500266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor-beta is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast.
    Sapino A; Bosco M; Cassoni P; Castellano I; Arisio R; Cserni G; Dei Tos AP; Fortunati N; Catalano MG; Bussolati G
    Mod Pathol; 2006 Apr; 19(4):599-606. PubMed ID: 16554735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit.
    Sawyer EJ; Poulsom R; Hunt FT; Jeffery R; Elia G; Ellis IO; Ellis P; Tomlinson IP; Hanby AM
    J Pathol; 2003 May; 200(1):59-64. PubMed ID: 12692842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD117 expression in breast phyllodes tumors correlates with adverse pathologic parameters and reduced survival.
    Tan WJ; Thike AA; Tan SY; Tse GM; Tan MH; Bay BH; Tan PH
    Mod Pathol; 2015 Mar; 28(3):352-8. PubMed ID: 25216225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study.
    Tan PH; Jayabaskar T; Yip G; Tan Y; Hilmy M; Selvarajan S; Bay BH
    Mod Pathol; 2005 Dec; 18(12):1527-34. PubMed ID: 16258510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Kit expression and mutations in phyllodes tumors of the breast.
    Bose P; Dunn ST; Yang J; Allen R; El-Khoury C; Tfayli A
    Anticancer Res; 2010 Nov; 30(11):4731-6. PubMed ID: 21115932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased c-kit (CD117) expression in malignant mammary phyllodes tumors.
    Tse GM; Putti TC; Lui PC; Lo AW; Scolyer RA; Law BK; Karim R; Lee CS
    Mod Pathol; 2004 Jul; 17(7):827-31. PubMed ID: 15044924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phyllodes tumor: a clinicopathologic and immunohistochemical study of 30 cases.
    Esposito NN; Mohan D; Brufsky A; Lin Y; Kapali M; Dabbs DJ
    Arch Pathol Lab Med; 2006 Oct; 130(10):1516-21. PubMed ID: 17090194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroepithelial lesions; The WHO spectrum.
    Krings G; Bean GR; Chen YY
    Semin Diagn Pathol; 2017 Sep; 34(5):438-452. PubMed ID: 28688536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant phyllodes tumours of the breast display increased stromal p53 protein expression.
    Millar EK; Beretov J; Marr P; Sarris M; Clarke RA; Kearsley JH; Lee CS
    Histopathology; 1999 Jun; 34(6):491-6. PubMed ID: 10383692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear survivin expression in stromal cells of phyllodes tumors and fibroadenomas of the breast.
    Hirano H; Matsushita K; Okimura A; Yoshida T; Kizaki T; Ito T
    Anticancer Res; 2014 Mar; 34(3):1251-3. PubMed ID: 24596368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast.
    Kuijper A; van der Groep P; van der Wall E; van Diest PJ
    Breast Cancer Res; 2005; 7(5):R808-18. PubMed ID: 16168127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-kit overexpression correlates with KIT gene copy numbers increases in phyllodes tumors of the breast.
    Liu J; Liu X; Feng X; Liu J; Lv S; Zhang W; Niu Y
    Breast Cancer Res Treat; 2015 Jan; 149(2):395-401. PubMed ID: 25534827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phyllodes tumors and fibroadenoma common beginning and different ending.
    Oprić S; Oprić D; Gugić D; Granić M
    Coll Antropol; 2012 Mar; 36(1):235-41. PubMed ID: 22816226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages.
    Silverman JS; Tamsen A
    Histopathology; 1996 Nov; 29(5):411-9. PubMed ID: 8951485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A subset of malignant phyllodes tumors harbors alterations in the Rb/p16 pathway.
    Cimino-Mathews A; Hicks JL; Sharma R; Vang R; Illei PB; De Marzo A; Emens LA; Argani P
    Hum Pathol; 2013 Nov; 44(11):2494-500. PubMed ID: 23916291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD34 and bcl-2 in phyllodes tumours, fibroadenomas and spindle cell lesions of the breast.
    Moore T; Lee AH
    Histopathology; 2001 Jan; 38(1):62-7. PubMed ID: 11135048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-derived growth factor expression in phyllodes tumors and fibroadenomas of the breast.
    Feakins RM; Wells CA; Young KA; Sheaff MT
    Hum Pathol; 2000 Oct; 31(10):1214-22. PubMed ID: 11070114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplifications of EGFR gene and protein expression of EGFR, Her-2/neu, c-kit, and androgen receptor in phyllodes tumor of the prostate.
    Wang X; Jones TD; Zhang S; Eble JN; Bostwick DG; Qian J; Lopez-Beltran A; Montironi R; Harris JJ; Cheng L
    Mod Pathol; 2007 Feb; 20(2):175-82. PubMed ID: 17192792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic landscapes of breast fibroepithelial tumors.
    Tan J; Ong CK; Lim WK; Ng CC; Thike AA; Ng LM; Rajasegaran V; Myint SS; Nagarajan S; Thangaraju S; Dey S; Nasir ND; Wijaya GC; Lim JQ; Huang D; Li Z; Wong BH; Chan JY; McPherson JR; Cutcutache I; Poore G; Tay ST; Tan WJ; Putti TC; Ahmad BS; Iau P; Chan CW; Tang AP; Yong WS; Madhukumar P; Ho GH; Tan VK; Wong CY; Hartman M; Ong KW; Tan BK; Rozen SG; Tan P; Tan PH; Teh BT
    Nat Genet; 2015 Nov; 47(11):1341-5. PubMed ID: 26437033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.